Abstract 4223: Mouse clinical trials (MCT) and other comprehensive pharmacology approaches highlight protein arginine methyltransferase 1 (PRMT1) targeting in various solid tumors with promising efficacy and combined mode-of-actions (MoAs) beyond epigenetic regulation
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Hui Shi, Xingnian Fu, Yilin Liu, Qiugeng Ouyang, Jiaxin Huang, Long Wang, Shuning Xing, Youzhen Wang, Yuan Mi, Haiping Wu
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409630805